Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.

Gary Cutter,Volker Knappertz,Nissim Sasson,David Ladkani

Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.

2016

Gary Cutter
Volker Knappertz
Nissim Sasson
David Ladkani

Background The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were analyzed using a propensity score model.

Keywords:

Neurosurgery
Pathology
Physical therapy
Laquinimod
Interferon beta-1a
Multiple sclerosis
Neurochemistry
Propensity score matching
Neurology
Medicine
Covariate
Interferon beta-1b
Placebo
Randomized controlled trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations